Series introduction: molecular and cellular basis of septic shock.
This series of overviews was contributed by participants of a Keystone Symposium, which was convened in early 2003 to address the topic of septic shock in an interdisciplinary manner. This occasion reflects a resurgence of interest in septic shock as a disease that may soon be approachable by new therapeutic interventions.
Bucala
Rick
R
The Anlyan Center, Department of Medicine and Pathology, Yale University School of Medicine, New Haven, CT 06520, USA. richard.bucala@yale.edu
D000276:Adjuvants, Immunologic; D000818:Animals; D006801:Humans; D007249:Inflammation / Q000276:immunology; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
D000276:Adjuvants, Immunologic